Evolent Health Inc (NYSE:EVH)
$ 22.5 0.47 (2.13%) Market Cap: 2.58 Bil Enterprise Value: 3.06 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 66/100

Evolent Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 09:30PM GMT
Release Date Price: $24.51 (+3.42%)
Anne Elizabeth Samuel
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. Welcome to the JPMorgan Healthcare Conference. My name is Annie Samuel, and I'm the health care technology and distribution analyst here at JPMorgan. We're very excited to have Evolent here with us today. With us are CEO, Seth Blackley; and CFO, John Johnson. We're going to have them do their presentation. And following that, we're going to do an interactive Q&A session. So if you have a question, please use the blue ask a question button in the portal, and we'll be sure to take questions from the audience.

So with that, let me turn it over to Seth.

Seth Barrie Blackley
Evolent Health, Inc. - Co-Founder, CEO & Director

Thank you, Annie, and welcome to the Evolent presentation. Sorry, we're not all cramped into the Westin St. Francis together, but we'll have together nonetheless. As Annie said, I'm Seth Blackley, CEO and Co-Founder. I'm joined by John Johnson, our CFO.

The agenda for the presentation is shown here, and I'll cover the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot